Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04579120 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT04579120 · ClinicalTrials.gov record · last posted 2026-06-08

Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)

Name: Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND) — clinical trial record (NCT04579120)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: HASD_PIB_IND

StatusRecruiting

PhaseNot specified

SponsorTammie L. S. Benzinger, MD, PhD

Started2021-09-01

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

To identify factors that signal the transition from asymptomatic (preclinical) to symptomatic Alzheimer disease (AD).

Amendment record 10 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 10 times since 2020-10-01; most recent amendment 2026-06-04. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2021-07-19

Status change Not Yet Recruiting→Recruitingv5

Trial Details

NCT Number	NCT04579120
Lead Sponsor	Tammie L. S. Benzinger, MD, PhD
Conditions	Alzheimer Disease
Enrollment	650 participants
Start Date	2021-09-01
Primary Completion	2027-11 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2026-06-08